SOPHiA GENETICS director reports initial holdings

SOPHiA GENETICS SA director Didier Hirsch filed an initial ownership report.

Rhea-AI Filing Summary

SOPHiA GENETICS SA director Didier Hirsch filed an initial ownership report. He holds 220,496 ordinary shares, including 33,784 shares to be delivered upon settlement of a restricted share unit award that vests in full at the company’s next annual shareholders’ meeting, subject to continued service.

He also holds fully vested and exercisable share options over 140,000 ordinary shares at an exercise price of 4.2100 per share expiring on June 25, 2030, and options over 49,751 ordinary shares at 3.0400 per share expiring on June 18, 2035.

Insider Trade Summary

3 transactions reported

Mixed 3 txns

Insider HIRSCH DIDIER

Role Director

Type	Security	Shares	Price	Value
holding	Share Option (Right to Buy)	--	--	--
holding	Share Option (Right to Buy)	--	--	--
holding	Ordinary Shares	--	--	--

Holdings After Transaction: Share Option (Right to Buy) — 189,751 contracts (Direct); Ordinary Shares — 220,496 shares (Direct)

Footnotes (3)

1. F1. Includes 33,784 ordinary shares to be delivered in settlement of a restricted share unit award ("RSU"). Each RSU represents a contingent right to receive one ordinary share of the Issuer, vesting subject to the Reporting Person's continued service with the Issuer. The RSUs were granted on June 18, 2025 and vest 100% as of the date of the Issuer's next scheduled annual meeting of shareholders.
2. F2. The share options are fully vested and exercisable.
3. F3. The share options were granted on June 18, 2025 and vest 100% as of the date of the Issuer's next scheduled annual meeting of shareholders, subject to the Reporting Person's continued service to the Issuer through the relevant vesting date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Didier Hirsch’s Form 3 filing show for SOPHiA GENETICS (SOPH)?

The Form 3 shows director Didier Hirsch initially reporting ownership of 220,496 ordinary shares of SOPHiA GENETICS SA and multiple share option awards over additional shares, establishing his equity stake as of the reporting date.

How many SOPHiA GENETICS ordinary shares does Didier Hirsch beneficially own?

Didier Hirsch reports beneficial ownership of 220,496 ordinary shares. This figure includes shares already held plus 33,784 additional ordinary shares to be delivered when a restricted share unit award settles, assuming vesting conditions are satisfied.

What restricted share units are disclosed for SOPHiA GENETICS director Didier Hirsch?

The filing notes 33,784 ordinary shares will be delivered on settlement of a restricted share unit award granted on June 18, 2025, which vests 100% at the next annual shareholders’ meeting, subject to his continued service with the company.

What stock options does Didier Hirsch hold in SOPHiA GENETICS?

He holds fully vested share options over 140,000 ordinary shares at 4.2100 per share expiring June 25, 2030, and options over 49,751 ordinary shares at 3.0400 per share expiring June 18, 2035, all on ordinary shares.

Are Didier Hirsch’s SOPHiA GENETICS share options vested and exercisable?

Yes. The disclosure states that the share options are fully vested and exercisable. They were granted on June 18, 2025, with vesting tied to the next annual shareholders’ meeting and conditioned on his continued service with SOPHiA GENETICS SA.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/18/2026 - 09:46 AM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

HIRSCH DIDIER

(Last) (First) (Middle)

C/O SOPHIA GENETICS INC.

401 PARK DRIVE, FLOOR 5

(Street)

BOSTON MASSACHUSETTS 02215

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
SOPHiA GENETICS SA [ SOPH ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares	220,496(1)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Share Option (Right to Buy)	(2)	06/25/2030	Ordinary Shares	140,000	$4.21	D
Share Option (Right to Buy)	(3)	06/18/2035	Ordinary Shares	49,751	$3.04	D

Explanation of Responses:

1. Includes 33,784 ordinary shares to be delivered in settlement of a restricted share unit award ("RSU"). Each RSU represents a contingent right to receive one ordinary share of the Issuer, vesting subject to the Reporting Person's continued service with the Issuer. The RSUs were granted on June 18, 2025 and vest 100% as of the date of the Issuer's next scheduled annual meeting of shareholders.

2. The share options are fully vested and exercisable.

3. The share options were granted on June 18, 2025 and vest 100% as of the date of the Issuer's next scheduled annual meeting of shareholders, subject to the Reporting Person's continued service to the Issuer through the relevant vesting date.

Remarks:

Exhibit list - Exhibit 24 - Power of Attorney

	/s/ Elimara Brunetto as Attorney-in-fact for Didier Hirsch	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)